Risk factors for first venous thromboembolism around pregnancy: a population-based cohort study from the United Kingdom

Blood ◽  
2013 ◽  
Vol 121 (19) ◽  
pp. 3953-3961 ◽  
Author(s):  
Alyshah Abdul Sultan ◽  
Laila J. Tata ◽  
Joe West ◽  
Linda Fiaschi ◽  
Kate M. Fleming ◽  
...  

Key Points Antepartum, we found that established risk factors only had a modest effect on rates of VTE. Postpartum, we found that among other factors, women with stillbirth or preterm birth had high rates of VTE.

Blood ◽  
2014 ◽  
Vol 124 (18) ◽  
pp. 2872-2880 ◽  
Author(s):  
Alyshah Abdul Sultan ◽  
Matthew J. Grainge ◽  
Joe West ◽  
Kate M. Fleming ◽  
Catherine Nelson-Piercy ◽  
...  

Key Points For women with preeclampsia, BMI >30 kg/m2, infection, or those having cesarean delivery, VTE risk remained elevated for 6 weeks postpartum. For women with postpartum hemorrhage or preterm birth, the relative rate of VTE was only increased for the first 3 weeks postpartum.


Blood ◽  
2014 ◽  
Vol 123 (25) ◽  
pp. 3972-3978 ◽  
Author(s):  
Cheng E. Chee ◽  
Aneel A. Ashrani ◽  
Randolph S. Marks ◽  
Tanya M. Petterson ◽  
Kent R. Bailey ◽  
...  

Key Points VTE recurrence risk in patients with cancer can be stratified by cancer type, stage, stage progression, and presence of leg paresis. Patients with cancer at high VTE recurrence risk should be considered for secondary prophylaxis.


2019 ◽  
Vol 36 (9) ◽  
pp. 887-894 ◽  
Author(s):  
Thanos Karatzias ◽  
Philip Hyland ◽  
Aoife Bradley ◽  
Marylène Cloitre ◽  
Neil P. Roberts ◽  
...  

2007 ◽  
Vol 22 (4) ◽  
pp. 186-191 ◽  
Author(s):  
J R H Scurr ◽  
J H Scurr

Objectives: To report the outcome of 100 consecutive medicolegal claims referred to one of the authors (1990–2003) following the development of venous thromboembolism (VTE) in surgical patients. Methods: A retrospective analysis of the experience of a vascular surgeon acting as an expert witness in the United Kingdom. Results: Prophylaxis had been provided to 43 claimants with risk factors, who, unfortunately, still developed a VTE and alleged negligence. Twenty-nine claims involved patients who had not received prophylaxis because they were at low risk. In 25/28 claims where no prophylaxis was provided, despite identifiable VTE risk factors, the claim was successful. Claimants who developed a VTE that had been managed incorrectly were successful whether they had received prophylaxis or not. Settlement amounts, where disclosed, are reported. Conclusions: Failure to perform a risk assessment and to provide appropriate venous thromboprophylaxis in surgical patients is considered negligent. Clinicians looking after all hospitalized patients who are not assessing their patients' risk for VTE and/or not providing appropriate prophylaxis are at risk of being accused of negligence.


Sign in / Sign up

Export Citation Format

Share Document